- Home
- RXRX vs DFIN Comparison
RXRX vs DFIN Comparison
Compare RXRX & DFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RXRX
- DFIN
- Stock Information
- Founded
- RXRX 2013
- DFIN 1983
- Country
- RXRX United States
- DFIN United States
- Employees
- RXRX N/A
- DFIN N/A
- Industry
- RXRX Biotechnology: Pharmaceutical Preparations
- DFIN Other Consumer Services
- Sector
- RXRX Health Care
- DFIN Consumer Discretionary
- Exchange
- RXRX Nasdaq
- DFIN Nasdaq
- Market Cap
- RXRX 2.6B
- DFIN 1.9B
- IPO Year
- RXRX 2021
- DFIN N/A
- Fundamental
- Price
- RXRX $7.05
- DFIN $61.48
- Analyst Decision
- RXRX Buy
- DFIN Strong Buy
- Analyst Count
- RXRX 5
- DFIN 3
- Target Price
- RXRX $9.25
- DFIN $76.33
- AVG Volume (30 Days)
- RXRX 16.7M
- DFIN 238.5K
- Earning Date
- RXRX 02-25-2025
- DFIN 02-18-2025
- Dividend Yield
- RXRX N/A
- DFIN N/A
- EPS Growth
- RXRX N/A
- DFIN 18.18
- EPS
- RXRX N/A
- DFIN 3.18
- Revenue
- RXRX $65,184,000.00
- DFIN $802,100,000.00
- Revenue This Year
- RXRX $60.17
- DFIN $1.75
- Revenue Next Year
- RXRX $19.88
- DFIN $4.27
- P/E Ratio
- RXRX N/A
- DFIN $19.71
- Revenue Growth
- RXRX 37.64
- DFIN 1.74
- 52 Week Low
- RXRX $5.60
- DFIN $56.02
- 52 Week High
- RXRX $15.74
- DFIN $71.01
- Technical
- Relative Strength Index (RSI)
- RXRX 53.24
- DFIN 57.37
- Support Level
- RXRX $6.65
- DFIN $60.24
- Resistance Level
- RXRX $7.86
- DFIN $63.74
- Average True Range (ATR)
- RXRX 0.64
- DFIN 1.44
- MACD
- RXRX 0.00
- DFIN 0.22
- Stochastic Oscillator
- RXRX 69.95
- DFIN 77.84
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.
About DFIN Donnelley Financial Solutions Inc.
Donnelley Financial Solutions Inc is a global risk and compliance solutions company. The company provides regulatory filing and deal solutions via its software-as-a-service, technology-enabled services, and print and distribution solutions to public and private companies, mutual funds, and other regulated investment firms. The company operates in four segments: Capital Markets - Software Solutions, Capital Markets - Compliance and Communications Management, Investment Companies - Software Solutions and Investment Companies - Compliance and Communications Management. Its geographical segments are the United States( US), Europe, Asia, Canada, and others, of which the US accounts for the vast majority of its total revenue.